SENS PubMed Publication Search
Iron retardation in lysosome protects senescent cells from ferroptosis
Aging (Albany NY). 2024 Apr 26:16. doi: 10.18632/aging.205777.
Yujing Feng 1, Huaiqing Wei 2, Meng Lyu 3, Zhiyuan Yu 3, Jia Chen 4, Xinxing Lyu 3, Fengfeng Zhuang 1
Abstract:
Ferroptosis, an iron-triggered modality of cellular death, has been reported to closely relate to human aging progression and aging-related diseases. However, the involvement of ferroptosis in the development and maintenance of senescent cells still remains elusive. Here, we established a doxorubicin-induced senescent HSkM cell model and found that both iron accumulation and lipid peroxidation increase in senescent cells. Moreover, such iron overload in senescent cells has changed the expression panel of the ferroptosis-response proteins. Interestingly, the iron accumulation and lipid peroxidation does not trigger ferroptosis-induced cell death. Oppositely, senescent cells manifest resistance to the ferroptosis inducers, compared to the proliferating cells. To further investigate the mechanism of ferroptosis-resistance for senescent cells, we traced the iron flux in cell and found iron arrested in lysosome. Moreover, disruption of lysosome functions by chloroquine and LLOMe dramatically triggered the senescent cell death. Besides, the ferroitinophagy-related proteins FTH1/FTL and NCOA4 knockdown also increases the senescent cell death. Thus, we speculated that iron retardation in lysosome of senescent cells is the key mechanism for ferroptosis resistance. And the lysosome is a promising target for senolytic drugs to selectively clear senescent cells and alleviate the aging related diseases.
PMID: 38683121
Free Full-Text: https://www.aging-us.com/article/205777/text
Tags: cell culture, Chloroquine, Ferritinophagy, FTH1, FTL, iron, LLOMe, lysosomes, NCOA4, senolytics